Global aesthetics leader Croma-Pharma has announced the launch of Croma Revitalis, a cutting-edge skin booster specifically designed to revitalise the delicate perioral and lateral orbital areas, where signs of ageing such as dryness, fine lines, and loss of elasticity commonly appear first. This advanced injectable solution delivers clinically proven improvements in hydration, skin tone, and elasticity—helping to restore a more youthful, radiant complexion.
At the heart of Revitalis is a powerful combination of non-crosslinked high molecular weight hyaluronic acid (HA) and glycerol. HA works by deeply hydrating the skin and supporting tissue regeneration, while also offering anti-inflammatory and healing benefits. Glycerol enhances these effects by protecting the skin’s barrier, boosting moisture retention, and stabilising the HA matrix for extended efficacy.
Developed through Croma’s advanced manufacturing process, the formulation ensures optimal purity, safety, and performance. The HA used in Revitalis is of exceptionally high molecular weight, contributing to its potent hydrating properties and its role in dermal repair.
Clinically backed and designed for immediate and long-lasting results, Croma Revitalis has shown measurable improvements in skin quality from the very first treatment. Patients reported a visible boost in hydration, improved elasticity, and smoother skin texture. At week 12, 91.1% of patients were satisfied with their results, reinforcing the product’s impact and reliability in real-world use.
With the addition of Revitalis, Croma-Pharma continues to expand its comprehensive aesthetics portfolio, which includes botulinum toxin, dermal fillers, lifting threads, polynucleotides, PRP and biostimulators. As a trusted European manufacturer, Croma remains at the forefront of minimally invasive aesthetics, combining science, innovation, and quality to deliver results-driven skincare solutions.
FURTHER INFORMATION
Croma-Pharma
E: info.uk@cromapharma.com
